Results 101 to 110 of about 3,861 (173)

Signal detection and analysis of adverse events associated with sevelamer post-marketing based on the FAERS database. [PDF]

Medicine (Baltimore)
Cao J, Yang N, Huang C.
europepmc   +1 more source

Real-World Evidence for Sevelamer vs Calcium-Containing Phosphate Binders in Long-Term Effectiveness and Safety Among Patients with Non-Dialysis CKD: The REVEAL Study. [PDF]

Adv Ther
Li P, Li C, Liang S, Sun X, Guo X, Xu X, Hao L, Chen X, Feng Z, Cai G.   +9 more
europepmc   +1 more source

Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM). [PDF]

Kidney360
Block GA, Bleyer AJ, Silva AL, Weiner DE, Lynn RI, Yang Y, Rosenbaum DP, Chertow GM, PHREEDOM Study Investigators.   +8 more
europepmc   +1 more source

Comparison of the effects of non-calcium and calcium-based phosphate binders on fibroblast growth factor-23 levels in patients with CKD-mineral and bone disorder: a meta-analysis of randomized controlled trials. [PDF]

BMC Nephrol
Cha S, Baek M, Jung C, Kim H.
europepmc   +1 more source

Assessing the real-world drug safety of sevelamer for hyperphosphatemia: Insights from a comprehensive analysis of the FDA adverse event reporting system (FAERS) database. [PDF]

Medicine (Baltimore)
Shao X, Yang H, Tan C, Liu J, Zhou L.
europepmc   +1 more source

Pharmacological Management of Secondary Hyperparathyroidism in Dialysis Patients: A Narrative Review of Calcimimetics, Vitamin D Analogs, and Phosphate Binders. [PDF]

Cureus
Alwashahi H, Unnikrishnan Meenakshi D.
europepmc   +1 more source

Phosphate-latest news and ongoing trials. [PDF]

Clin Kidney J
Parpia AS, Kumra R, Mansell C, Harel Z, Perl J, Ben-Bassat OK, Wald R.   +6 more
europepmc   +1 more source

Serum activin A and bone metabolism in patients undergoing hemodialysis. [PDF]

Osteoporos Int
Nakagawa Y, Takahashi H, Takahashi Y, Hyodo T, Hida M, Suga T, Kakuta T, Tomita Y, Nakamura M, Komaba H.   +9 more
europepmc   +1 more source

Risk factors for drug-related gastrointestinal ulcer:a retrospective pharmacovigilance study. [PDF]

Front Pharmacol
Jiang S, Wang M, Ren X, Jiang Z, Zhu Q, Dai S, Li J, Zhao Z, Han L.   +8 more
europepmc   +1 more source

Kayexalate-Induced Ischemic Colitis: Revisiting a Forgotten but Preventable Cause of Colonic Necrosis. [PDF]

Cureus
Mehdaoui C, Daoudi C, Haloui A, Bennani A, Koulali H, Elmqaddam O, Zazour A, Ismaili Z, Kharrasse G.   +8 more
europepmc   +1 more source